Not sure if this is anything new but it's dated today, May 19th. 2026.
https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-229657/dftx-ex99\_1.htm
Form 8 k
I have not had a chance to go over it yet.
https://ir.definiumtx.com/sec-filings/all-sec-filings/content/0001193125-26-229657/dftx-ex99\_1.htm
Form 8 k
I have not had a chance to go over it yet.
Just added shares to both my IRA and Roth accounts this am. The two recent down weeks in the chart while holding the 10-week moving average suggest a potential upward trend. Chart showing higher lows and hopefully higher highs coming. 🍀🐂
Not sure how this affects any approval that defenium may have coming up in the near future.
I don't anticipate any breaking news, although perhaps there might be an update regarding the timeline for phase three. I hope they delay any dilution until after the announcement and filing for approval for phase three.
What are your thoughts on this afternoon?
I noticed a high call volume for the July 17 options.
Arya reiterated a buy rating for Nvidia stock and the price target of $300, based on 28 multiple of his estimate for price-to-earnings ratio excluding cash for calendar year 2027, which is within Nvidia’s historical forward year P/E range of 25 to 56.
https://www.thestreet.com/investing/stocks/bank-of-america-reiterates-buy-rating-nvidia-stock
Nice starting salary.
😎
Senior Director, Patient Services.
The starting base pay range for this position is $261,928.00 - $292,125.00. Compensation will be determined based on several factors including, but not limited to, skill set, years of experience, and the employee’s geographic location.
They did a small segment on the policies for psychedelics on CNBC and Definium Therapeutics was one of the four stocks on the board.
Once again I will ask can someone please help me why I cannot post a flair?